Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rexulti
Pharma
Lundbeck's new CEO van Zyl talks long-term growth plan
The new chief aims to strike M&A deals that will fill out Lundbeck's early pipeline as the company leans on growth drivers Rexulti and Vyepti.
Zoey Becker
Jan 23, 2024 9:02am
FDA rules key Otsuka marketing claim overstates Rexulti efficacy
Nov 13, 2023 8:05am
Lundbeck, Otsuka dial down the drama for Rexulti agitation ad
Oct 13, 2023 9:45am
Lundbeck, Otsuka run ad to push expanded Alzheimer's label
Jul 28, 2023 10:35am
Lundbeck hires UCB neurology exec as new CEO
Jun 26, 2023 11:24am
AbbVie's Rinvoq tops TV drug ad spenders' list
Jun 6, 2023 9:15am